-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
RVL Pharmaceuticals plc quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from 2017 to 2022.
- RVL Pharmaceuticals plc Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2023 was -$5.82M, a 56.2% increase year-over-year.
- RVL Pharmaceuticals plc annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$37.8M, a 30.9% increase from 2021.
- RVL Pharmaceuticals plc annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$54.7M, a 411% decline from 2020.
- RVL Pharmaceuticals plc annual Net Cash Provided by (Used in) Operating Activities for 2020 was $17.6M, a 47.6% decline from 2019.
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Growth (%)